# Shanghai Microport Endovascular Medtech Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shanghai-microport-endovascular-medtech-co

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.endovastec.com
- Latest round: Angel (Dec 19, 2016)
- Investors on record: 3

## About

Established in 2012 and based in Shanghai, China, Shanghai Microport Endovascular Medtech Co., Ltd. operates as a medical equipment developer dedicated to providing cardiac implantable devices. It owns four subsidiaries in Shanghai and the United States. The company acquired more than 280 authorized patents at home and abroad. It also acquired High-tech Enterprise Certificate. In 2019, Shanghai Microport Endovascular Medtech Co., Ltd. was listed on Shanghai Stock Exchange. In December 2023, Lord Abbett China Asset Management Co.,ltd., Caitong Fund Management Co., Ltd., and other investors invested CNY 1.8 billion in the company.

The company mainly provides aortic products and peripheral artery products. The aortic products include thoracic aortic stent system, abdominal aortic stent system, Hercules® balloon dilatation catheter, and intraoperative stent system. The peripheral artery products include peripheral artery balloon dilatation catheter and peripheral artery stent system. The company also provides solutions for aortic disease and peripheral vascular disease. The company's products have entered 1,900 hospitals across the country and have been sold to 28 countries and regions in Europe, Latin America, Southeast Asia and other places.

In 2022, the company's revenue is CNY 896 million, and its net income is CNY 352 million.

## Funding rounds

- Angel, Dec 19, 2016 — Jiuyou Fund, New Alliance Capital, ZJ Innopark

## Investors

- Jiuyou Fund (https://capitalatlas.ai/funds/jiuyou-fund) — Angel
- New Alliance Capital (https://capitalatlas.ai/funds/new-alliance-capital) — Angel
- ZJ Innopark — Angel